{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T07:26:30Z","timestamp":1782631590941,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["01.20.0003.00"],"award-info":[{"award-number":["01.20.0003.00"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The nucleocapsid (N) protein plays critical roles in coronavirus genome transcription and packaging, representing a key target for the development of novel antivirals, and for which structural information on ligand binding is scarce. We used a novel fluorescence polarization assay to identify small molecules that disrupt the binding of the N protein to a target RNA derived from the SARS-CoV-2 genome packaging signal. Several phenolic compounds, including L-chicoric acid\u00a0(CA), were identified as high-affinity N-protein ligands. The binding of CA to the N protein was confirmed by isothermal titration calorimetry, <jats:sup>1<\/jats:sup>H-STD and <jats:sup>15<\/jats:sup>N-HSQC NMR, and by the crystal structure of CA bound to the N protein C-terminal domain (CTD), further revealing a new modulatory site in the SARS-CoV-2\u00a0N protein. Moreover, CA reduced SARS-CoV-2 replication in cell cultures. These data thus open venues for the development of new antivirals targeting the N protein, an essential and yet underexplored coronavirus target.<\/jats:p>","DOI":"10.1038\/s41598-022-22576-4","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T13:06:55Z","timestamp":1667394415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Discovery and structural characterization of chicoric acid as a SARS-CoV-2 nucleocapsid protein ligand and RNA binding disruptor"],"prefix":"10.1038","volume":"12","author":[{"given":"Gustavo Fernando","family":"Mercaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Henrique Salviano","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Aparecida Heleno","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celisa Caldana Costa","family":"Tonoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Santos","family":"Soprano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Farinha","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline Cristina","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helder Veras Ribeiro","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica","family":"do Nascimento Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Guilherme","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Mattos","family":"Zeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey Fabricio Ziem","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luiz","family":"Proenca-Modena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Chaim","family":"Bajgelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana Aparecida","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo S\u00e9rgio","family":"Lopes-de-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur Torres","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Bruder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Elias","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio Luis","family":"Sfor\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleber Gomes","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Eduardo","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Migliorini","family":"Figueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Barretto Barbosa","family":"Trivella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"22576_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","volume":"78","author":"M Nicola","year":"2020","unstructured":"Nicola, M. et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int. J. Surg. 78, 185\u2013193 (2020).","journal-title":"Int. J. Surg."},{"key":"22576_CR2","doi-asserted-by":"crossref","unstructured":"Das, S., Wingender, P., Barrett, P., Pugacheva, E. & Magistretti, G. After-effects of the COVID-19 pandemic: Prospects for medium-term economic damage. In IMF Working Papers 2021, 1 (2021).","DOI":"10.5089\/9781513587905.001"},{"key":"22576_CR3","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19 \u2014 final report. N. Engl. J. Med. 383, 1813\u20131826 (2020).","journal-title":"N. Engl. J. Med."},{"key":"22576_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal, A. et al. Molnupiravir for oral treatment of Covid-19 in Nonhospitalized Patients. N. Engl. J. Med. 386, 509\u2013520 (2022).","journal-title":"N. Engl. J. Med."},{"key":"22576_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-03667-0","author":"M Kozlov","year":"2021","unstructured":"Kozlov, M. Merck\u2019s COVID pill loses its lustre: What that means for the pandemic. Nature https:\/\/doi.org\/10.1038\/d41586-021-03667-0 (2021).","journal-title":"Nature"},{"issue":"374","key":"22576_CR6","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"1979","author":"DR Owen","year":"2021","unstructured":"Owen, D. R. et al. An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19. Science 1979(374), 1586\u20131593 (2021).","journal-title":"Science"},{"key":"22576_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0140-6736(21)02657-X","volume":"399","author":"J Heskin","year":"2022","unstructured":"Heskin, J. et al. Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. The Lancet 399, 21\u201322 (2022).","journal-title":"The Lancet"},{"key":"22576_CR8","doi-asserted-by":"publisher","first-page":"830527","DOI":"10.3389\/fimmu.2021.830527","volume":"12","author":"M Shah","year":"2022","unstructured":"Shah, M. & Woo, H. G. Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies. Front. Immunol. 12, 830527 (2022).","journal-title":"Front. Immunol."},{"key":"22576_CR9","doi-asserted-by":"publisher","first-page":"e0240079","DOI":"10.1371\/journal.pone.0240079","volume":"15","author":"C Coelho","year":"2020","unstructured":"Coelho, C., Gallo, G., Campos, C. B., Hardy, L. & W\u00fcrtele, M. Biochemical screening for SARS-CoV-2 main protease inhibitors. PLoS ONE 15, e0240079 (2020).","journal-title":"PLoS ONE"},{"key":"22576_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1021\/acsptsci.0c00108","volume":"3","author":"W Zhu","year":"2020","unstructured":"Zhu, W. et al. Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening. ACS Pharmacol. Transl. Sci. 3, 1008\u20131016 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"22576_CR11","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1042\/BCJ20210244","volume":"478","author":"CT Lim","year":"2021","unstructured":"Lim, C. T. et al. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease. Biochem. J. 478, 2517\u20132531 (2021).","journal-title":"Biochem. J."},{"key":"22576_CR12","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.drudis.2021.05.012","volume":"26","author":"T Xu","year":"2021","unstructured":"Xu, T., Zheng, W. & Huang, R. High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directions. Drug Discov. Today 26, 2439\u20132444 (2021).","journal-title":"Drug Discov. Today"},{"key":"22576_CR13","doi-asserted-by":"publisher","first-page":"114013","DOI":"10.1016\/j.jviromet.2020.114013","volume":"288","author":"C Eydoux","year":"2021","unstructured":"Eydoux, C. et al. A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex. J. Virol. Methods 288, 114013 (2021).","journal-title":"J. Virol. Methods"},{"key":"22576_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00732-2","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates. Acta Pharmacol. Sin. https:\/\/doi.org\/10.1038\/s41401-021-00732-2 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"22576_CR15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/2472555220963667","volume":"25","author":"E Smith","year":"2020","unstructured":"Smith, E. et al. High-throughput screening for drugs that inhibit papain-like protease in SARS-CoV-2. SLAS Discov. Adv. Sci. Drug Discov. 25, 1152\u20131161 (2020).","journal-title":"SLAS Discov. Adv. Sci. Drug Discov."},{"key":"22576_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-020-00343-z","volume":"5","author":"Z-R Zhang","year":"2020","unstructured":"Zhang, Z.-R. et al. A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2. Signal Transduct. Target. Ther. 5, 218 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"22576_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12033-021-00299-7","volume":"63","author":"HA Rothan","year":"2021","unstructured":"Rothan, H. A. & Teoh, T. C. Cell-based high-throughput screening protocol for discovering antiviral inhibitors against SARS-COV-2 Main protease (3CLpro). Mol. Biotechnol. 63, 240\u2013248 (2021).","journal-title":"Mol. Biotechnol."},{"key":"22576_CR18","doi-asserted-by":"publisher","first-page":"105078","DOI":"10.1016\/j.antiviral.2021.105078","volume":"190","author":"J Zhao","year":"2021","unstructured":"Zhao, J. et al. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. Antiviral Res. 190, 105078 (2021).","journal-title":"Antiviral Res."},{"issue":"1","key":"22576_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1021\/acsptsci.1c00182","volume":"5","author":"K Gorshkov","year":"2022","unstructured":"Gorshkov, K. et al. SARS-CoV-2 Nucleocapsid protein TR-FRET assay amenable to high throughput screening. ACS Pharmacol. Transl. Sci. 5(1), 8\u201319 (2022).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"22576_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/v6082991","author":"R McBride","year":"2014","unstructured":"McBride, R., van Zyl, M. & Fielding, B. C. The coronavirus nucleocapsid is a multifunctional protein. Viruses https:\/\/doi.org\/10.3390\/v6082991 (2014).","journal-title":"Viruses"},{"key":"22576_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/v13061115","author":"Z Bai","year":"2021","unstructured":"Bai, Z., Cao, Y., Liu, W. & Li, J. The sars-cov-2 nucleocapsid protein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation. Viruses https:\/\/doi.org\/10.3390\/v13061115 (2021).","journal-title":"Viruses"},{"issue":"20","key":"22576_CR22","doi-asserted-by":"publisher","first-page":"e105938","DOI":"10.15252\/embj.2020105938","volume":"39","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design. EMBO J. 39(20), e105938 (2020).","journal-title":"EMBO J."},{"issue":"12","key":"22576_CR23","doi-asserted-by":"publisher","first-page":"e1009100","DOI":"10.1371\/journal.ppat.1009100","volume":"16","author":"DC Dinesh","year":"2020","unstructured":"Dinesh, D. C. et al. Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein. PLoS Pathogens 16(12), e1009100 (2020).","journal-title":"PLoS Pathogens"},{"issue":"7","key":"22576_CR24","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.apsb.2020.04.009","volume":"10","author":"S Kang","year":"2020","unstructured":"Kang, S. et al. Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm. Sin. B 10(7), 1228\u20131238 (2020).","journal-title":"Acta Pharm. Sin. B"},{"key":"22576_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jmb.2009.09.040","volume":"394","author":"NE Grossoehme","year":"2009","unstructured":"Grossoehme, N. E. et al. Coronavirus N Protein N-Terminal Domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes. J. Mol. Biol. 394, 544\u2013557 (2009).","journal-title":"J. Mol. Biol."},{"issue":"10","key":"22576_CR26","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1074\/jbc.M111.287763","volume":"287","author":"SC Keane","year":"2012","unstructured":"Keane, S. C., Liu, P., Leibowitz, J. L. & Giedroc, D. P. Functional transcriptional regulatory sequence (TRS) RNA binding and helix destabilizing determinants of Murine Hepatitis Virus (MHV) Nucleocapsid (N) protein. J. Biol. Chem. 287(10), 7063\u20137073 (2012).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"22576_CR27","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jmb.2007.02.069","volume":"368","author":"CY Chen","year":"2007","unstructured":"Chen, C. Y. et al. Structure of the SARS coronavirus Nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA. J. Mol. Biol. 368(4), 1075\u20131086 (2007).","journal-title":"J. Mol. Biol."},{"key":"22576_CR28","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1128\/JVI.03866-13","volume":"88","author":"L Kuo","year":"2014","unstructured":"Kuo, L., Koetzner, C. A., Hurst, K. R. & Masters, P. S. Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein. J. Virol. 88, 4451\u20134465 (2014).","journal-title":"J. Virol."},{"key":"22576_CR29","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.molcel.2020.11.025","volume":"80","author":"CR Carlson","year":"2020","unstructured":"Carlson, C. R. et al. Phosphoregulation of phase separation by the SARS-CoV-2 N protein suggests a biophysical basis for its dual functions. Mol. Cell 80, 1092-1103.e4 (2020).","journal-title":"Mol. Cell"},{"issue":"1","key":"22576_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19843-1","volume":"11","author":"A Savastano","year":"2020","unstructured":"Savastano, A., Ib\u00e1\u00f1ez de Opakua, A., Rankovic, M. & Zweckstetter, M. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. Nat. Commun. 11(1), 1\u201310 (2020).","journal-title":"Nat. Commun."},{"issue":"24","key":"22576_CR31","doi-asserted-by":"publisher","first-page":"e106478","DOI":"10.15252\/embj.2020106478","volume":"39","author":"TM Perdikari","year":"2020","unstructured":"Perdikari, T. M. et al. SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs. EMBO J. 39(24), e106478 (2020).","journal-title":"EMBO J."},{"issue":"1","key":"22576_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"S Lu","year":"2021","unstructured":"Lu, S. et al. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein. Nat. Commun. 12(1), 1\u201315 (2021).","journal-title":"Nat. Commun."},{"key":"22576_CR33","doi-asserted-by":"publisher","first-page":"e1010121","DOI":"10.1371\/journal.pcbi.1010121","volume":"18","author":"HV Ribeiro-Filho","year":"2022","unstructured":"Ribeiro-Filho, H. V. et al. Structural dynamics of SARS-CoV-2 nucleocapsid protein induced by RNA binding. PLoS Comput. Biol. 18, e1010121 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"22576_CR34","doi-asserted-by":"publisher","first-page":"13848","DOI":"10.1128\/JVI.79.22.13848-13855.2005","volume":"79","author":"P-K Hsieh","year":"2005","unstructured":"Hsieh, P.-K. et al. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is Nucleocapsid dependent. J. Virol. 79, 13848\u201313855 (2005).","journal-title":"J. Virol."},{"key":"22576_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12929-018-0449-x","volume":"25","author":"W-C Hsin","year":"2018","unstructured":"Hsin, W.-C. et al. Nucleocapsid protein-dependent assembly of the RNA packaging signal of Middle East respiratory syndrome coronavirus. J. Biomed. Sci. 25, 47 (2018).","journal-title":"J. Biomed. Sci."},{"key":"22576_CR36","doi-asserted-by":"publisher","first-page":"153310","DOI":"10.1016\/j.phymed.2020.153310","volume":"85","author":"\u015e Adem","year":"2021","unstructured":"Adem, \u015e et al. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19. Phytomedicine 85, 153310 (2021).","journal-title":"Phytomedicine"},{"key":"22576_CR37","doi-asserted-by":"publisher","first-page":"8420","DOI":"10.1128\/JVI.72.10.8420-8424.1998","volume":"72","author":"PJ King","year":"1998","unstructured":"King, P. J. & Robinson, W. E. Resistance to the anti-human immunodeficiency virus type 1 Compound l -Chicoric acid results from a single mutation at amino acid 140 of integrase. J. Virol. 72, 8420\u20138424 (1998).","journal-title":"J. Virol."},{"key":"22576_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.virol.2004.06.005","volume":"326","author":"RA Reinke","year":"2004","unstructured":"Reinke, R. A. et al. l-Chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro. Virology 326, 203\u2013219 (2004).","journal-title":"Virology"},{"key":"22576_CR39","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1248\/bpb.b14-00137","volume":"37","author":"H-L Zhang","year":"2014","unstructured":"Zhang, H.-L. et al. Evaluation of hepatocyteprotective and anti-hepatitis B virus properties of Cichoric acid from Cichorium Intybus leaves in cell culture. Biol. Pharm. Bull. 37, 1214\u20131220 (2014).","journal-title":"Biol. Pharm. Bull."},{"key":"22576_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0022-2836(68)90205-2","volume":"33","author":"BW Matthews","year":"1968","unstructured":"Matthews, B. W. Solvent content of protein crystals. J. Mol. Biol. 33, 491\u2013497 (1968).","journal-title":"J. Mol. Biol."},{"key":"22576_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43556-020-00001-4","volume":"1","author":"R Zhou","year":"2020","unstructured":"Zhou, R., Zeng, R., von Brunn, A. & Lei, J. Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein. Mol. Biomed. 1, 2 (2020).","journal-title":"Mol. Biomed."},{"key":"22576_CR42","doi-asserted-by":"publisher","first-page":"624765","DOI":"10.3389\/fchem.2020.624765","volume":"8","author":"M Yang","year":"2021","unstructured":"Yang, M. Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-terminal domain reveals a novel recognition mechanism for viral transcriptional regulatory sequences. Front. Chem. 8, 624765 (2021).","journal-title":"Front. Chem."},{"key":"22576_CR43","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1128\/JVI.02001-08","volume":"83","author":"C-K Chang","year":"2009","unstructured":"Chang, C.-K. et al. Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus Nucleocapsid protein: Implications for Ribonucleocapsid protein packaging. J. Virol. 83, 2255\u20132264 (2009).","journal-title":"J. Virol."},{"issue":"1","key":"22576_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18709-w","volume":"11","author":"A Douangamath","year":"2020","unstructured":"Douangamath, A. et al. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat. Commun. 11(1), 1\u201311 (2020).","journal-title":"Nat. Commun."},{"issue":"8","key":"22576_CR45","doi-asserted-by":"publisher","first-page":"e00900","DOI":"10.1128\/AAC.00900-20","volume":"64","author":"C Salgado-Benvindo","year":"2020","unstructured":"Salgado-Benvindo, C. et al. Suramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycle. Antimicrob. Agents Chemother. 64(8), e00900-20 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"22576_CR46","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.foodres.2011.04.027","volume":"44","author":"JM Landete","year":"2011","unstructured":"Landete, J. M. Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health. Food Res. Int. 44, 1150\u20131160 (2011).","journal-title":"Food Res. Int."},{"key":"22576_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fmicb.2020.00182","volume":"11","author":"P Li","year":"2020","unstructured":"Li, P. et al. Identification of Chebulinic acid and Chebulagic acid as novel influenza viral neuraminidase inhibitors. Front. Microbiol. 11, 182 (2020).","journal-title":"Front. Microbiol."},{"issue":"1","key":"22576_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-017-1620-8","volume":"17","author":"A Kesharwani","year":"2017","unstructured":"Kesharwani, A. et al. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids. BMC Complement. Altern. Med. 17(1), 1\u201311 (2017).","journal-title":"BMC Complement. Altern. Med."},{"issue":"1","key":"22576_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-13-187","volume":"13","author":"LT Lin","year":"2013","unstructured":"Lin, L. T. et al. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol. 13(1), 1\u201315 (2013).","journal-title":"BMC Microbiol."},{"key":"22576_CR50","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2147\/IJN.S31379","volume":"7","author":"C Roh","year":"2012","unstructured":"Roh, C. A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide. Int. J. Nanomed. 7, 2173. https:\/\/doi.org\/10.2147\/IJN.S31379 (2012).","journal-title":"Int. J. Nanomed."},{"key":"22576_CR51","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1021\/jm500089r","volume":"57","author":"S-Y Lin","year":"2014","unstructured":"Lin, S.-Y. et al. Structural basis for the identification of the N-terminal domain of coronavirus Nucleocapsid protein as an antiviral target. J. Med. Chem. 57, 2247\u20132257 (2014).","journal-title":"J. Med. Chem."},{"issue":"1","key":"22576_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1365-2710.2003.00530.x","volume":"29","author":"A Matthias","year":"2004","unstructured":"Matthias, A. et al. Permeability studies of Alkylamides and Caffeic acid conjugates from Echinacea using a Caco-2 cell monolayer model. J. Clin. Pharm. Ther. 29(1), 7\u201313 (2004).","journal-title":"J. Clin. Pharm. Ther."},{"issue":"13","key":"22576_CR53","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1016\/j.bmc.2006.02.030","volume":"14","author":"TT Charvat","year":"2006","unstructured":"Charvat, T. T., Lee, D. J., Robinson, W. E. & Chamberlin, A. R. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase. Bioorg. Med. Chem. 14(13), 4552\u20134567r (2006).","journal-title":"Bioorg. Med. Chem."},{"key":"22576_CR54","doi-asserted-by":"publisher","first-page":"635701","DOI":"10.3389\/fimmu.2021.635701","volume":"12","author":"LA Peroni","year":"2021","unstructured":"Peroni, L. A. et al. Serological testing for COVID-19, immunological surveillance, and exploration of protective antibodies. Front. Immunol. 12, 635701 (2021).","journal-title":"Front. Immunol."},{"key":"22576_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08940886.2021.1994310","volume":"34","author":"A Nascimento","year":"2021","unstructured":"Nascimento, A. et al. Launch of the Manac\u00e1 Beamline at Sirius: First protein crystallography structures and new opportunities for pharmaceutical development using synchrotrons. Synchrotron Radiat. News 34, 3\u201310 (2021).","journal-title":"Synchrotron Radiat. News"},{"key":"22576_CR56","doi-asserted-by":"crossref","unstructured":"Kabsch, W. XDS. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 125\u2013132 (2010)","DOI":"10.1107\/S0907444909047337"},{"key":"22576_CR57","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1110\/ps.0350503","volume":"12","author":"KA Kantardjieff","year":"2003","unstructured":"Kantardjieff, K. A. & Rupp, B. Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals. Protein Sci. 12, 1865\u20131871 (2003).","journal-title":"Protein Sci."},{"issue":"4","key":"22576_CR58","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1107\/S090744491003982X","volume":"67","author":"PR Evans","year":"2011","unstructured":"Evans, P. R. An introduction to data reduction: Space-group determination, scaling and intensity statistics. Acta Crystallogr. Sect. D Biol. Crystallogr. 67(4), 282\u2013292 (2011).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"22576_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1107\/S0907444909042589","volume":"66","author":"A Vagin","year":"2010","unstructured":"Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. D Biol. Crystallogr. 66, 22\u201325 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"22576_CR60","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"22576_CR61","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","volume":"53","author":"GN Murshudov","year":"1997","unstructured":"Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240\u2013255 (1997).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"22576_CR62","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1107\/S0907444909029436","volume":"65","author":"NW Moriarty","year":"2009","unstructured":"Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. electronic ligand builder and optimization workbench (eLBOW): A tool for ligand coordinate and restraint generation. Acta Crystallogr. D Biol. Crystallogr. 65, 1074\u20131080 (2009).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"22576_CR63","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"22576_CR64","doi-asserted-by":"publisher","first-page":"100606","DOI":"10.1016\/j.softx.2020.100606","volume":"12","author":"JV da Silva Guerra","year":"2020","unstructured":"da Silva Guerra, J. V. et al. ParKVFinder: A thread-level parallel approach in biomolecular cavity detection. SoftwareX 12, 100606 (2020).","journal-title":"SoftwareX"},{"key":"22576_CR65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/BF02192855","volume":"2","author":"M Piotto","year":"1992","unstructured":"Piotto, M., Saudek, V. & Sklen\u00e1\u0159, V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2, 661\u2013665 (1992).","journal-title":"J. Biomol. NMR"},{"key":"22576_CR66","unstructured":"Cavanagh, J., Fairbrother, W., III, A. P. & Skelton, N. Protein NMR Spectroscopy: Principles and Practice. 2nd Edition (ed. Academic Press). 885 pg (2007)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22576-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22576-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22576-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T21:03:03Z","timestamp":1667422983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22576-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22576"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22576-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18500"}}